Alico, Inc. Announces Financial Results for Fiscal Year 2017
Dec 11, 2017 21:45 pm UTC| Business
FORT MYERS, Fla., Dec. 11, 2017 -- Alico, Inc. (“Alico” or the “Company”) (NASDAQ:ALCO) today announces financial results for the fourth quarter and fiscal year ended September 30, 2017. For the fiscal year, the...
California Water Service Launches Fourth Annual Student Water Conservation Competition
Dec 11, 2017 21:41 pm UTC| Business
SAN JOSE, Calif., Dec. 11, 2017 -- (NYSE:CWT) -- California Water Service (Cal Water) and its partner, the North American Association for Environmental Education (NAAEE), announced today the launch of the fourth annual...
Dec 11, 2017 21:34 pm UTC| Business
DETROIT, Dec. 11, 2017 -- When dedicated community members, including those touched by cancer, come together to support cancer research at Karmanos, it’s another way of describing the Barbara Ann Karmanos Cancer...
Artisan Partners Asset Management Inc. Reports November 2017 Assets Under Management
Dec 11, 2017 21:33 pm UTC| Business
MILWAUKEE, Dec. 11, 2017 -- Artisan Partners Asset Management Inc. (NYSE:APAM) today reported that its assets under management (AUM) as of November 30, 2017 totaled $115.6 billion. Separate accounts(1) accounted for...
Dec 11, 2017 21:30 pm UTC| Business
SAN DIEGO, Calif., Dec. 11, 2017 -- Fate Therapeutics, Inc. (NASDAQ:FATE), a clinical-stage biopharmaceutical company dedicated to the development of programmed cellular immunotherapies for cancer and immune disorders,...
Franklin Resources, Inc. Announces Month-End Assets Under Management
Dec 11, 2017 21:30 pm UTC| Business
SAN MATEO, Calif., Dec. 11, 2017 -- Franklin Resources, Inc. (Franklin Templeton Investments) (NYSE:BEN) today reported preliminary month-end assets under management of 753.2 billion at November 30, 2017, compared to...
Minerva Neurosciences Names Richard Russell President
Dec 11, 2017 21:30 pm UTC| Business
WALTHAM, Mass., Dec. 11, 2017 -- Minerva Neurosciences, Inc. (NASDAQ:NERV), a clinical-stage biopharmaceutical company focused on the development of therapies to treat central nervous system (CNS) disorders, today...